Metrics as of 10/15/2026, 07:40 AM (Berlin time), refresh in progress.
Labcorp Holdings Stock
Labcorp Holdings Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Country
- United States
- CEO
- Adam H. Schechter
- Employees
- 71,000
- Market cap
- $26.4 B
- IPO
- 29/03/1990
Labcorp Holdings Inc. is a healthcare company headquartered in Burlington, US. The company offers vital diagnostic laboratory services that enable medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. Its business…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Labcorp Holdings stock: price history
1D
+2.4%
1W
+3.5%
1M
+0.3%
6M
+22.0%
YTD
+29.6%
1Y
+15.0%
2Y
+50.0%
5Y
+39.3%
10Y
+178.7%
Next earnings date
Next earnings date
28/10/2026 (in 11 days)
Volatility around earnings
~42% stronger price swings than usual
Labcorp Holdings stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Business model & megatrends
Robust business model that benefits noticeably from at least one megatrend.
2 more assignments (Enabler/Second row) Pro-only.
Labcorp Holdings Inc. offers comprehensive diagnostic laboratory services to a broad spectrum of healthcare stakeholders, including medical professionals, healthcare facilities, pharmaceutical companies, researchers, and private patients. By providing test results, the company supports informed medical decision-making. The business model focuses primarily on the Diagnostics segment with a geographic concentration in North America and a complementary international presence.
- Revenue model
- Transactional
- Recurring revenue
- High
- Pricing power
- Moderate
- Moat
- Narrow
- Moat type
- Efficient scale
- Capital intensity
- High
- Customer concentration
- Unknown
Ask the agents about Labcorp Holdings
Analyst assessment of Labcorp Holdings
PRICE TARGET LOW
US$306.00
CONSENSUS
US$346.57
MEDIAN
US$352.00
PRICE TARGET HIGH
US$380.00
0
STRONG BUY
26
BUY
9
HOLD
0
SELL
0
STRONG SELL
35
TOTAL · Buy
As of: 21/09/2026
Labcorp Holdings stock metrics
P/E
26.71
P/B
3.09
EV/EBITDA
15.33
RETURN ON EQUITY
3.5%
NET MARGIN
8.0%
DEBT/EQUITY
0.79
DIVIDEND YIELD
0.9%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
99.6%
FLOAT SHARES
80,773,978
AVG. DAILY VOLUME (30D)
756,130
Insider transactions (SEC)
ANDERSON KERRII B
Schechter Adam H
Summy Amy B.
Wilkinson Peter J
Wilkinson Peter J
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: +2.4%
Forums (Reddit)
Institutional holders
Dividends & Stock splits
Dividends
Stock splits
Smart Money
Register for free
Register now to see which funds are invested
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Comparable stocks
Frequently asked questions about Labcorp Holdings stock
What does Labcorp Holdings do?
Labcorp Holdings Inc. is a company in the Healthcare sector, Medical - Diagnostics & Research industry, headquartered in United States.
The CEO is Adam H. Schechter, the company employs around 71,000 people.
The IPO was on 29/03/1990; the stock trades on NYSE under the ticker LH.
What do analysts say about Labcorp Holdings stock?
35 analysts rate the stock, the consensus is Buy (as of 21/09/2026).
The average price target is US$346.57, ranging from US$306.00 to US$380.00, with a median of US$352.00.
This is an external assessment, not a statement by Market Jury.
When does Labcorp Holdings report next?
The next earnings date is 28/10/2026.
Around past earnings, price swings were roughly 42% stronger than usual.
Does Labcorp Holdings pay a dividend?
Yes. The last dividend was US$0.72 per share, ex-date 28/08/2026, paid on 11/09/2026.
The dividend yield is 0.9% (as of 30/06/2026).
Which stocks are comparable to Labcorp Holdings?
Comparable stocks include Thermo Fisher Scientific, Danaher, Natera, Agilent Technologies, IQVIA Holdings, Waters, Illumina and IDEXX Laboratories.
How can I get Labcorp Holdings stock analyzed?
Clicking "Analyze stock" lets five strategies assess Labcorp Holdings against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.